1-14 of 14
Gary Kelloff
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 978: Functional characterization and a real-world clinical laboratory pilot of the Foundation for the National Institutes of Health’s (FNIH) circulating tumor DNA (ctDNA) quality control materials (QCMs)

Free
Cloud P. Paweletz, Thomas D. Forbes, Grace A. Heavey, Laura M. Yee, Hua-Jun He, Zhiyong He, Dana E. Connors, Daniel Stetson, Susan Keating, Kenneth D. Cole, Gary Kelloff, Robert T. McCormack, Mickey P. Williams, Chris Karlovich
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 978.
https://doi.org/10.1158/1538-7445.AM2024-978
Published: 22 March 2024
View article titled, Abstract 978: Functional characterization and a real-world clinical laboratory pilot of the Foundation for the National Institutes of Health’s (FNIH) circulating tumor DNA (ctDNA) quality control materials (QCMs)
Journal Articles

2-Difluoromethylornithine and Dehydroepiandrosterone Inhibit Mammary Tumor Progression but not Mammary or Prostate Tumor Initiation in C3(1)/SV40 T/t-antigen Transgenic Mice

Free
Jeffrey E. Green, Masa-Aki Shibata, Eiko Shibata, Richard C. Moon, Miriam R. Anver, Gary Kelloff, Ronald Lubet
Journal: Cancer Research
Cancer Res (2001) 61 (20): 7449–7455.
Published: 01 October 2001
View article titled, 2-Difluoromethylornithine and Dehydroepiandrosterone Inhibit Mammary Tumor Progression but not Mammary or Prostate Tumor Initiation in C3(1)/SV40 T/t-antigen Transgenic Mice
Open the PDF for 2-Difluoromethylornithine and Dehydroepiandrosterone Inhibit Mammary Tumor Progression but not Mammary or Prostate Tumor Initiation in C3(1)/SV40 T/t-antigen Transgenic Mice in another window
Journal Articles

The Cyclooxygenase-2 Inhibitor Celecoxib Is a Potent Preventive and Therapeutic Agent in the Min Mouse Model of Adenomatous Polyposis

Free
Russell F. Jacoby, Karen Seibert, Carolyn E. Cole, Gary Kelloff, Ronald A. Lubet
Journal: Cancer Research
Cancer Res (2000) 60 (18): 5040–5044.
Published: 01 September 2000
View article titled, The Cyclooxygenase-2 Inhibitor Celecoxib Is a Potent Preventive and Therapeutic Agent in the Min Mouse Model of Adenomatous Polyposis
Open the PDF for The Cyclooxygenase-2 Inhibitor Celecoxib Is a Potent Preventive and Therapeutic Agent in the Min Mouse Model of Adenomatous Polyposis in another window
Journal Articles

Chemopreventive Efficacy of Combined Piroxicam and Difluoromethylornithine Treatment of Apc Mutant Min Mouse Adenomas, and Selective Toxicity against Apc Mutant Embryos

Free
Russell F. Jacoby, Carolyn E. Cole, Kendra Tutsch, Michael A. Newton, Gary Kelloff, Ernest T. Hawk, Ronald A. Lubet
Journal: Cancer Research
Cancer Res (2000) 60 (7): 1864–1870.
Published: 01 April 2000
View article titled, Chemopreventive Efficacy of Combined Piroxicam and Difluoromethylornithine Treatment of Apc Mutant Min Mouse Adenomas, and Selective Toxicity against Apc Mutant Embryos
Open the PDF for Chemopreventive Efficacy of Combined Piroxicam and Difluoromethylornithine Treatment of Apc Mutant Min Mouse Adenomas, and Selective Toxicity against Apc Mutant Embryos in another window
Journal Articles

Chemoprevention of Colon Cancer by Specific Cyclooxygenase-2 Inhibitor, Celecoxib, Administered during Different Stages of Carcinogenesis

Free
Bandaru S. Reddy, Yoshinobu Hirose, Ronald Lubet, Vernon Steele, Gary Kelloff, Susan Paulson, Karen Seibert, Chinthalapally V. Rao
Journal: Cancer Research
Cancer Res (2000) 60 (2): 293–297.
Published: 01 January 2000
View article titled, Chemoprevention of Colon Cancer by Specific Cyclooxygenase-2 Inhibitor, Celecoxib, Administered during Different Stages of Carcinogenesis
Open the PDF for Chemoprevention of Colon Cancer by Specific Cyclooxygenase-2 Inhibitor, Celecoxib, Administered during Different Stages of Carcinogenesis in another window
Journal Articles

Difluoromethylornithine Chemoprevention of Epidermal Carcinogenesis in K14-HPV16 Transgenic Mice

Free
Jeffrey M. Arbeit, Rebeccah R. Riley, Bing Huey, Carl Porter, Gary Kelloff, Ronald Lubet, Jerrold M. Ward, Dan Pinkel
Journal: Cancer Research
Cancer Res (1999) 59 (15): 3610–3620.
Published: 01 August 1999
View article titled, Difluoromethylornithine Chemoprevention of Epidermal Carcinogenesis in K14-HPV16 Transgenic Mice
Open the PDF for Difluoromethylornithine Chemoprevention of Epidermal Carcinogenesis in K14-HPV16 Transgenic Mice in another window
Journal Articles

Enhancement of Experimental Colon Cancer by Genistein

Free
Chinthalapally V. Rao, Chung-Xiou Wang, Barbara Simi, Ronald Lubet, Gary Kelloff, Vernon Steele, Bandaru S. Reddy
Journal: Cancer Research
Cancer Res (1997) 57 (17): 3717–3722.
Published: 01 September 1997
View article titled, Enhancement of Experimental Colon Cancer by Genistein
Open the PDF for Enhancement of Experimental Colon Cancer by Genistein in another window
Journal Articles

Inhibition of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced Lymphoma Formation by Oltipraz

Free
Chinthalapally V. Rao, Abraham Rivenson, Edith Zang, Vernon Steele, Gary Kelloff, Bandaru S. Reddy
Journal: Cancer Research
Cancer Res (1996) 56 (15): 3395–3398.
Published: 01 August 1996
View article titled, Inhibition of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced Lymphoma Formation by Oltipraz
Open the PDF for Inhibition of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced Lymphoma Formation by Oltipraz in another window
Journal Articles

Chemopreventive Efficacy of Arylalkyl Isothiocyanates and N-Acetylcysteine for Lung Tumorigenesis in Fischer Rats

Free
Fung-Lung Chung, Gary Kelloff, Vernon Steele, Brian Pittman, Edith Zang, Ding Jiao, Jeffrey Rigotty, Chang-In Choi, Abraham Rivenson
Journal: Cancer Research
Cancer Res (1996) 56 (4): 772–778.
Published: 01 February 1996
View article titled, Chemopreventive Efficacy of Arylalkyl Isothiocyanates and N-Acetylcysteine for Lung Tumorigenesis in Fischer Rats
Open the PDF for Chemopreventive Efficacy of Arylalkyl Isothiocyanates and N-Acetylcysteine for Lung Tumorigenesis in Fischer Rats in another window
Journal Articles

Chemoprevention of Colon Carcinogenesis by Sulindac, a Nonsteroidal Anti-inflammatory Agent

Free
Chinthalapally V. Rao, Abraham Rivenson, Barbara Simi, Edith Zang, Gary Kelloff, Vernon Steele, Bandaru S. Reddy
Journal: Cancer Research
Cancer Res (1995) 55 (7): 1464–1472.
Published: 01 April 1995
View article titled, Chemoprevention of Colon Carcinogenesis by Sulindac, a Nonsteroidal Anti-inflammatory Agent
Open the PDF for Chemoprevention of Colon Carcinogenesis by Sulindac, a Nonsteroidal Anti-inflammatory Agent in another window
Journal Articles

Chemoprevention of Colon Carcinogenesis by Organosulfur Compounds

Free
Bandaru S. Reddy, Chinthalapally V. Rao, Abraham Rivenson, Gary Kelloff
Journal: Cancer Research
Cancer Res (1993) 53 (15): 3493–3498.
Published: 01 August 1993
View article titled, Chemoprevention of Colon Carcinogenesis by Organosulfur Compounds
Open the PDF for Chemoprevention of Colon Carcinogenesis by Organosulfur Compounds in another window
Journal Articles

Chemoprevention of Colon Carcinogenesis by Dietary Administration of Piroxicam, α-Difluoromethylornithine, 16α-Fluoro-5-androsten-17-one, and Ellagic Acid Individually and in Combination

Free
Chinthalapally V. Rao, Kenji Tokumo, Jeff Rigotty, Edith Zang, Gary Kelloff, Bandaru S. Reddy
Journal: Cancer Research
Cancer Res (1991) 51 (17): 4528–4534.
Published: 01 September 1991
View article titled, Chemoprevention of Colon Carcinogenesis by Dietary Administration of Piroxicam, α-Difluoromethylornithine, 16α-Fluoro-5-androsten-17-one, and Ellagic Acid Individually and in Combination
Open the PDF for Chemoprevention of Colon Carcinogenesis by Dietary Administration of Piroxicam, α-Difluoromethylornithine, 16α-Fluoro-5-androsten-17-one, and Ellagic Acid Individually and in Combination in another window
Journal Articles

Chemoprevention of Colon Carcinogenesis by Concurrent Administration of Piroxicam, a Nonsteroidal Antiinflammatory Drug with d,l-α-Difluoromethylornithine, an Ornithine Decarboxylase Inhibitor, in Diet1

Free
Bandaru S. Reddy, Jayashree Nayini, Kenji Tokumo, Jeff Rigotty, Edith Zang, Gary Kelloff
Journal: Cancer Research
Cancer Res (1990) 50 (9): 2562–2568.
Published: 01 May 1990
View article titled, Chemoprevention of Colon Carcinogenesis by Concurrent Administration of Piroxicam, a Nonsteroidal Antiinflammatory Drug with d,l-α-Difluoromethylornithine, an Ornithine Decarboxylase Inhibitor, in Diet1
Open the PDF for Chemoprevention of Colon Carcinogenesis by Concurrent Administration of Piroxicam, a Nonsteroidal Antiinflammatory Drug with d,l-α-Difluoromethylornithine, an Ornithine Decarboxylase Inhibitor, in Diet1 in another window
Journal Articles

Dose-related Inhibition of Colon Carcinogenesis by Dietary Piroxicam, a Nonsteroidal Antiinflammatory Drug, during Different Stages of Rat Colon Tumor Development

Free
Bandaru S. Reddy, Hiroshi Maruyama, Gary Kelloff
Journal: Cancer Research
Cancer Res (1987) 47 (20): 5340–5346.
Published: 01 October 1987
View article titled, Dose-related Inhibition of Colon Carcinogenesis by Dietary Piroxicam, a Nonsteroidal Antiinflammatory Drug, during Different Stages of Rat Colon Tumor Development
Open the PDF for Dose-related Inhibition of Colon Carcinogenesis by Dietary Piroxicam, a Nonsteroidal Antiinflammatory Drug, during Different Stages of Rat Colon Tumor Development in another window